Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TyTAN: Lapatinib + Paclitaxel in HER2+ Gastric Cancer
NCT00486954Phase 3Completed
- Sponsor
- GSK
- Start
- Jul 2007
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of lapatinib in gastric cancer (GC), sponsored by GSK. Started Jul 2007; status: completed.
02
Drugs
lapatinib
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00486954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00486954.